Literature DB >> 11818211

Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells.

M Takeoka1, T Ehara, J Sagara, S Hashimoto, S Taniguchi.   

Abstract

Calponin h1 (CNh1) is an actin-binding protein that is expressed mainly in smooth muscle cells and is known to regulate smooth muscle contraction. Recently, re-expression of CNh1 in leiomyosarcoma cell lines is reported to suppress cell proliferation and tumorigenicity. However, little is known about the associated cellular structural and functional changes. Since CNh1 is also detected in normal fibroblasts, we hypothesised that CNh1 would also inhibit cell proliferation of the fibrosarcoma cells, HT1080, in which CNh1 is suppressed. An expression vector of human CNh1 complementary DNA was transfected into human HT1080 cells by a calcium-phosphate precipitation method. CNh1-transfected cells exhibited a flattened morphology with organised actin filaments, a significant decrease in cell motility and enhancement in adhesion to fibronectin in association with an increase in integrin alpha5beta1 expression. Anchorage-independent growth and tumorigenicity in nude mice were suppressed in the CNh1-transfected cells. Our results suggest that CNh1 may have a role as a tumour suppressor in human fibrosarcoma by influencing cytoskeletal activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818211     DOI: 10.1016/s0959-8049(01)00390-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

Review 1.  Calponin isoforms CNN1, CNN2 and CNN3: Regulators for actin cytoskeleton functions in smooth muscle and non-muscle cells.

Authors:  Rong Liu; J-P Jin
Journal:  Gene       Date:  2016-03-10       Impact factor: 3.688

2.  Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.

Authors:  Nan Su; Maomao Chen; Siyu Chen; Can Li; Yangli Xie; Ying Zhu; Yaozong Zhang; Ling Zhao; Qifen He; Xiaolan Du; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

3.  Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.

Authors:  Linda A Scott; J Keith Vass; E Kenneth Parkinson; David A F Gillespie; Joseph N Winnie; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  Calponin h1 suppresses tumor growth of Src-induced transformed 3Y1 cells in association with a decrease in angiogenesis.

Authors:  Miwako Kaneko; Michiko Takeoka; Misae Oguchi; Yoko Koganehira; Hiroshi Murata; Takashi Ehara; Minoru Tozuka; Toshiaki Saida; Shun'ichiro Taniguchi
Journal:  Jpn J Cancer Res       Date:  2002-08

5.  Expression of Myoepithelial Markers in Mammary Carcinomas of 119 Pet Rabbits.

Authors:  Sophie Degner; Heinz-Adolf Schoon; Sebastian Degner; Mathias Baudis; Claudia Schandelmaier; Heike Aupperle-Lellbach; Sandra Schöniger
Journal:  Animals (Basel)       Date:  2019-09-28       Impact factor: 2.752

6.  miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.

Authors:  Zheng Wang; Tian-En Li; Mo Chen; Jun-Jie Pan; Kun-Wei Shen
Journal:  Aging (Albany NY)       Date:  2020-01-27       Impact factor: 5.682

7.  Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.

Authors:  Khalid Akkour; Ibrahim O Alanazi; Assim A Alfadda; Hani Alhalal; Afshan Masood; Mohthash Musambil; Anas M Abdel Rahman; Moudi A Alwehaibi; Maria Arafah; Ali Bassi; Hicham Benabdelkamel
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

8.  Loss of calponin h1 confers anoikis resistance and tumor progression in the development of high-grade serous carcinoma originating from the fallopian tube epithelium.

Authors:  Kai-Hung Wang; Sung-Chao Chu; Tang-Yuan Chu
Journal:  Oncotarget       Date:  2017-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.